Clinical trial NCT04250480: Changes in Cognition During a 24-h Simulated Military Operation
Official title: Changes in Cognition During a 24-h Simulated Military Operation (SUSOP). Influence of β-alanine Supplementation and Markers of Classical Monocyte Recruitment
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cognitive Impairment
Keywords: beta-alanine
immune cells
Lead sponsor: University of Central Florida
Sponsor class: OTHER
Collaborators: name: National Strength and Conditioning Association
First posted: 2020-01-31
Enrollment: 40
Sex: MALE
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: Sustained military operations (SUSOPs) result in psychological stress and cognitive dysfunction, which may be related to the recruitment of classical monocytes into the brain.

Goals:

* To investigate the effect of sustained-release beta-alanine on changes in cognition and markers of immune cell recruitment during a 24-hour simulated military operation.
* To examine associations between changes cognition and changes in markers mediating immune cell recruitment.

Detailed description: Sustained military operations (SUSOPs) expose soldiers to a multitude of stressors, including sustained physical activity, caloric deficit, and sleep deprivation. Several studies have shown that the combination of these factors result in psychological stress, which often leads to significant cognitive impairment.

Psychological stress has been shown to result in activation of neuroendocrine pathways that signal into the periphery and relay information from the brain to the immune system. This process is generally characterized by elevations of several key pro-inflammatory cytokines, chemokines, secondary messengers and reactive oxygen species. Notably, peripheral classical monocytes are reported to undergo recruitment to the brain during periods of psychological stress following priming by cytokines secreted from activated microglia.

Carnosine, an endogenous dipeptide consisting of beta-alanine and L-histidine, has been shown to inhibit the synthesis of inflammatory and oxidative mediators in microglia in vitro. Beta-alanine, which is the rate limiting amino acid in carnosine formation has been shown to increase carnosine concentrations in various regions of the brain in rodents which been associated with biochemical changes that resulted in favorable improvements in resilience to stress exposure. However, data on the effects of beta-alanine supplementation on cognition in humans is less clear. Further, the effect of beta-alanine supplementation on systemic and cellular mediators of monocyte recruitment has not been examined.

Goals:

* To investigate the effect of sustained-release beta-alanine on changes in psychological stress and cognition using Automated Neuropsychological Assessment Metric (ANAM) cognitive assessments during a 24-hour simulated military operation.
* To examine the effect of sustained-release beta-alanine on monocyte chemoattractant protein-1 (MCP-1), interleukin-8, Lymphocyte function-associated antigen-1 (CD11a), macrophage-1-antigen (CD11b) expression and C-C chemokine receptor 2 (CCR2) expression on neutrophils and classical monocytes during a 24-hour simulated military operation.
* To examine associations between MCP-1, interleukin-8, CD11a, CD11b, CCR2 and a composite measure of cognition derived from ANAM assessment scores during a 24-hour simulated military operation.

Method:

Double-blind placebo controlled trial compared the effect of supplementation with sustained release beta-alanine (12 grams per day) versus placebo (equivalent amount of rice powder) on cognition and monocyte responses during a 24-hour simulated military operation consisting of sleep-restriction, caloric restriction, and acute and sustained periods military specific physical activity.

Supplementation occurred over a period of 14 days prior to completion of the simulated military operation. ANAM tests were assessed and blood samples taken upon arrival to the lab for the 24 hour simulated operation (0 hours) and at 12, 18 and 24 hours during the SUSOP.

Eligibility criteria: Inclusion Criteria:

* Participants in this study will be males aged 18-35, preferably with military training or are current Reserve Officers' Training Corps cadets
* Free of any physical limitations (determined by medical and activity history questionnaire \[MHQ\] and the physical activity readiness questionnaire \[PAR-Q+\]).
* Participants will be required to be recreationally-active (defined according to American College of Sports Medicine standards of at least 150 minutes exercise per week).
* Participants must be willing abstain from dietary supplementation throughout the duration of the study.
* Participant understands the study procedures and signs forms providing informed consent to participate in the study.

Exclusion Criteria:

* Individual does not provide consent to participate in this study.
* Inability to perform physical exercise (determined by health and activity questionnaire \[MHQ\] and physical activity readiness questionnaire \[PAR-Q+\]). That is Answering "Yes" to any question on the PAR-Q+, or having a pre-existing condition such as musculoskeletal injury, back pain, chronic pain etc. that the investigative team perceives will prevent a participant from safely completing the protocol.
* Taking any other nutritional supplement or performance-enhancing drug (determined from health and activity questionnaire).
* Regularly taking any type of prescription or over-the-counter medication, or having any chronic illnesses, which require medical care.
* Inability to complete any of the exercise performance testing on the familiarization day.

Primary outcomes:
measure: Symptoms checklist
timeFrame: Change from 0 at 12, 18 and 24 hours
measure: COGcomp (composite measure of cognition)
timeFrame: Change from 0 at 12, 18 and 24 hours
measure: Monocyte chemoattractant protein-1 (MCP-1)
timeFrame: Change from 0 at 12, 18 and 24 hours
measure: Macrophage-1-antigen (CD11b)
timeFrame: Change from 0 at 12, 18 and 24 hours
measure: C-C chemokine receptor 2 (CCR2)
timeFrame: Change from 0 at 12, 18 and 24 hours
measure: Interleukin-8
timeFrame: Change from 0 at 12, 18 and 24 hours
measure: Lymphocyte function-associated antigen-1 (CD11a)
timeFrame: Change from 0 at 12, 18 and 24 hours
Secondary outcomes:
Other outcomes:
Locations:
city: Orlando
country: United States
facility: Kinesiology Research Labs
state: Florida
Study officials:
affiliation: University of Central Florida
name: Adam J Wells, PhD
role: PRINCIPAL_INVESTIGATOR
References: